The Centers for Disease Control and Prevention has given Emory University Vaccine Center's Hope Clinic $2.2 million for clinical trials of anti-HIV microbicides. Two different microbicide gels will be tested in the study, which is the first of its kind in Atlanta to evaluate the safety and acceptability of microbicides for healthy women and HIV-infected women. Patients will be recruited later this year. (AP)
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Stay up to date with the latest in LGBTQ+ news with The Advocate’s email newsletter, in your inbox five days a week.
@ 2026 Equal Entertainment LLC.
All rights reserved
All rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
The Latest
Support Independent Journalism
LGBTQ+ stories deserve to betold.
Your membership powers The Advocate's original reporting—stories that inform, protect, and celebrate our community.
Become a Member
FOR AS LITTLE AS $5. CANCEL ANYTIME.
More For You
Most Popular
@ 2026 Equal Entertainment LLC. All Rights reserved















